• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-21A
Device Problem Incomplete Coaptation (2507)
Patient Problem Valvular Insufficiency/ Regurgitation (4449)
Event Date 02/23/2022
Event Type  Injury  
Event Description
It was reported that on (b)(6) 2022: additional information was reviewed.Procedure description was updated.No changes were made to reportability assessments.All significant available information has been received.No additional requests for information are needed., a 21mm trifecta valve was implanted.The implanting physician reported that there were no procedural complications, and an echocardiogram performed post-procedure confirmed that the device was working as intended.The patient later returned to the hospital for a check up.During a transesophageal echocardiogram (tee), it was revealed that one of the valve cusps was stuck in an open position, causing severe regurgitation.On (b)(6) 2022, the device was explanted and replaced with a non-abbott valve.The patient was later discharged.
 
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Manufacturer Narrative
Please reference previous manufacturer report number 3005334138-2022-00174.Explant due to valves leaflet being stuck in an open position causing sever regurgitation was reported.One leaflet appeared pinched and was visibly underperforming during functional testing upon return of the valve to abbott.Functional testing at the time of manufacturing indicated the valve functioned normally.This test ensures proper leaflet coaptation and hemodynamic performance.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications, including inspection for proper leaflet coaptation.This was inclusive of a review of the manufacturing videos, which contained no evidence of anomalies during functional inspection.The cause of the reported event could not be conclusively determined, however it is possible the valve structure was damaged during implant or explant of the valve, which could have impacted the coaptation of the leaflets.
 
Event Description
It was reported that on (b)(6) 2022, a 21mm trifecta valve was implanted.The implanting physician reported that there were no procedural complications, and an echocardiogram performed post-procedure confirmed that the device was working as intended.The patient later returned to the hospital for a check up.During a transesophageal echocardiogram (tee), it was revealed that one of the valve cusps was stuck in an open position, causing severe regurgitation.On (b)(6) 2022, the device was explanted and replaced with a non-abbott valve.The patient was later discharged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key16438576
MDR Text Key310227819
Report Number2135147-2023-00665
Device Sequence Number1
Product Code LWR
UDI-Device Identifier05414734052023
UDI-Public05414734052023
Combination Product (y/n)N
Reporter Country CodeCE
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/24/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/11/2022
Device Model NumberTF-21A
Device Catalogue NumberTF-21A
Device Lot NumberBR00015668
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/27/2022
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/24/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/13/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient SexFemale
-
-